ZYMEWORKS INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ZYMEWORKS INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $51.95M.
- ZYMEWORKS INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $76.15M.
- ZYMEWORKS INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $25.48M, a 170.28% increase year-over-year.
- ZYMEWORKS INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $16.22M.
- ZYMEWORKS INC. payments for repurchase of common stock for fiscal 2025 was $41.70M, a 38.75% increase from fiscal 2024.
- ZYMEWORKS INC. payments for repurchase of common stock for fiscal 2024 was $30.05M.
- ZYMEWORKS INC. payments for repurchase of common stock for fiscal 2023 was $0.00.
- ZYMEWORKS INC. payments for repurchase of common stock for fiscal 2022 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $51.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $169.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $76.15M 10-Q · filed 2026-05-07 | $117.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $25.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $41.70M 10-K · filed 2026-03-02 |
| 2025-09-30 | $16.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $25.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $9.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $30.05M 10-K · filed 2026-03-02 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |